5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Thyroid Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, N; Fong, Y; Lin, SF; Riedl, C; Shah, JP; Szalay, AA; Timiryasova, T; Wong, RJ; Woo, Y; Yu, YA; Yu, Z; Zhang, Q | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Thyroid Neoplasms
| Article | Year |
|---|---|
Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus.
Topics: beta-Galactosidase; Carcinoma; Cell Division; Cell Line, Tumor; Galactosides; Green Fluorescent Proteins; Humans; In Vitro Techniques; Indoles; Luciferases; Mutagenesis; Oncolytic Virotherapy; Thyroid Neoplasms; Vaccinia virus; Virus Replication | 2007 |